Download presentation
Presentation is loading. Please wait.
Published byNickolas Hunt Modified over 5 years ago
1
High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Consortium for Improving Survival of Lymphoma Shin Young Hyun, June-Won Cheong, Soo-Jeong Kim, Yoo Hong Min, Deok-Hwan Yang, Jae-Sook Ahn, Won-Sik Lee, Hun-Mo Ryoo, Young Rok Do, Ho Sup Lee, Jae Hoon Lee, Sung Yong Oh, Cheolwon Suh, Ho-Young Yhim, Jin Seok Kim Biology of Blood and Marrow Transplantation Volume 20, Issue 1, Pages (January 2014) DOI: /j.bbmt Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Days to collect CD34+ cells ≥5.0 × 106 cells/kg. CTX indicates high-dose cyclophosphamide; VP-16, high-dose etoposide. Biology of Blood and Marrow Transplantation , 73-79DOI: ( /j.bbmt ) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.